PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 114 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 45.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $160,000 | -23.8% | 85,729 | +23.8% | 0.00% | 0.0% |
| Q1 2022 | $210,000 | +123.4% | 69,268 | +84.2% | 0.00% | – |
| Q4 2020 | $94,000 | +20.5% | 37,600 | 0.0% | 0.00% | – |
| Q3 2020 | $78,000 | -33.9% | 37,600 | -1.1% | 0.00% | -100.0% |
| Q2 2020 | $118,000 | +35.6% | 38,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $87,000 | -42.8% | 38,000 | -9.3% | 0.00% | – |
| Q4 2019 | $152,000 | +198.0% | 41,900 | +175.7% | 0.00% | – |
| Q1 2019 | $51,000 | +27.5% | 15,200 | 0.0% | 0.00% | – |
| Q4 2018 | $40,000 | -51.2% | 15,200 | +4.1% | 0.00% | – |
| Q3 2018 | $82,000 | -8.9% | 14,600 | -17.5% | 0.00% | – |
| Q2 2018 | $90,000 | -23.1% | 17,700 | +2.9% | 0.00% | -100.0% |
| Q1 2018 | $117,000 | – | 17,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |